ATS Corporation (ATS) Stock Forecast and Price Target (2026)
Last updated July 2026
Short answer
There is no meaningful analyst consensus for ATS Corporation (ATS): too few analysts publish estimates on it for an average target to mean anything. That is normal for smaller and newer companies and says nothing about the business. What is left is the setup, the drivers and the risks below, which you assess yourself rather than starting from someone else's model. Walnut is not an investment adviser.
Why ATS has no consensus price target
Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. That is the situation with ATS. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model rather than a consensus.
The August 2026 selloff reset the multiple more than it reset the business. Trailing GAAP earnings are small relative to the market cap (net income was about C$72 million in fiscal 2026, so trailing P/E screens in the 40s or higher), which is why ATS is more commonly valued on EV/EBITDA or free cash flow, where it sits near 10x EBITDA and around 8x to 10x trailing free cash flow after the drop. The gap between the trailing and forward earnings multiple is entirely a bet on whether the cost program and the nuclear plus radiopharmaceutical pipeline restore margin before backlog erosion shows up in revenue.
What could move ATS from here
In short: the drivers cited most often are Life sciences as the durable franchise, Nuclear and energy as the fastest-growing line, The Fixed Cost Transformation Program. The risk cited most often against it is aTS revenue is recognized on long-duration projects, so a handful of delayed customer awards can swing a quarter, and the June 2026 quarter is the live example: bookings down 5.3%, backlog down 8.7%, and a swing from C$24.3 million of net income to a small loss.
Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the ATS is it a buy page. This page deliberately stops at the numbers.
Investing in ATS Corporation with AI
Connect the broker you already use and ask Walnut's AI how ATS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the price target for ATS Corporation (ATS)?
+
There is no meaningful consensus price target for ATS, because too few analysts publish on it. That is common for smaller and newer companies. Where only one or two analysts cover a stock, an "average target" is really one person's model, so we do not print a number that would imply more agreement than exists. Check your broker's research tab for whatever individual coverage exists.
Why does ATS have no analyst forecast?
+
Sell-side coverage follows trading volume and banking relationships, so small caps, recent listings, and companies outside the major indices often carry little or none. A lack of coverage says nothing about the business itself. It does mean you are doing the analysis yourself rather than starting from someone else's model.
What could move ATS?
+
The drivers and the risks are laid out on this page and in more depth on the ATS "is it a buy" page. Without analyst estimates to anchor to, the honest framing is scenarios rather than a number.
Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a August 2026 data pull of published third-party research, are approximate, and change constantly. Verify current figures with your broker before acting on them.